VeriMomginsenoside rg4 est-il sûr pendant la grossesse ?
No harmonised CLP classification, SCCS opinion, or CIR safety assessment for ginsenoside Rg4 was found, and no animal or human reproductive/toxicology data specific to Rg4 indicating developmental or teratogenic effects were located in the searched literature. Identity/compound records (PubChem/supplier pages) confirm this is a high‑molecular‑weight ginsenoside (low likelihood of systemic reproductive hazard at cosmetic topical use). Sources: PubMed searches for reproductive effects found studies on other ginsenosides (e.g., Rg1, Rb1) but not Rg4; no authoritative safety assessment listing Rg4 as repro‑toxic. (PubChem/supplier records; PubMed; EWG).
Related ingredients
Frequently asked questions
- ginsenoside rg4 est-il sûr pendant la grossesse ?
- No harmonised CLP classification, SCCS opinion, or CIR safety assessment for ginsenoside Rg4 was found, and no animal or human reproductive/toxicology data specific to Rg4 indicating developmental or teratogenic effects were located in the searched literature. Identity/compound records (PubChem/supplier pages) confirm this is a high‑molecular‑weight ginsenoside (low likelihood of systemic reproductive hazard at cosmetic topical use). Sources: PubMed searches for reproductive effects found studies on other ginsenosides (e.g., Rg1, Rb1) but not Rg4; no authoritative safety assessment listing Rg4 as repro‑toxic. (PubChem/supplier records; PubMed; EWG).
- ginsenoside rg4 est-il sûr pendant l'allaitement ?
- No evidence was found that Rg4 is classified for reproductive or lactation hazard, and no studies showing transfer into milk or lactation toxicity for Rg4 were identified. By the priority rules, absence of CIR/SCCS/harmonised flags and lack of Rg4‑specific lactation data leads to default low hazard and mechanism scores. (Sources: PubChem/supplier pages; literature search on PubMed; EWG ingredient summary).
- ginsenoside rg4 est-il sûr pour la peau de bébé ?
- No infant‑specific toxicity data for Rg4 were identified. Dermal exposure assessment: Rg4 is a large, polar glycoside (MW ~767) typical of ginsenosides; such molecules have low dermal permeability, so adult topical exposure is likely negligible (e=0). However, given immature infant barrier and instruction in scoring, exposure for baby skin is increased by +1 to e=1 in absence of infant data. No infant dermal adverse effects or studies were found. (Sources: PubChem/supplier data on structure/MW; lack of reproductive/infant studies on PubMed; EWG ingredient page).
- Comment VeriMom évalue-t-il ginsenoside rg4 ?
- VeriMom évalue ginsenoside rg4 à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à ginsenoside rg4 pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à ginsenoside rg4 basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.